Real-time enrollment status for this primary knee osteoarthritis clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 6:53 PM UTC
| NCT Number | NCT07580716 |
| Recruiting Status | Recruiting |
| Condition | Primary Knee Osteoarthritis |
| Phase | PHASE2 |
| Target Enrollment | 270 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Enlivex Therapeutics Ltd. |
| Last Updated on CT.gov | August 26, 2026 (6 days ago) |
As of September 1, 2026: Clinical trial NCT07580716 is currently recruiting participants. This phase2 study for primary knee osteoarthritis is actively seeking new participants at 4 locations across the United States. The study is sponsored by Enlivex Therapeutics Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07580716 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07580716 was last updated 6 days ago (August 26, 2026). HelloStudys verifies this status automatically.